Literature DB >> 35317497

Determinants of Disability in Progressive Onset Multiple Sclerosis.

Melih Tütüncü1, Mesude Tütüncü2, Sabahattin Saip1, Aksel Siva1.   

Abstract

Introduction: To describe the clinical and socio-demographic profiles of the patients with the progressive onset Multiple Sclerosis (MS) and to explore the determinants of disability. Method: This is a retrospective study, which was conducted in a university hospital. Patients with a progressive clinical course at onset were included in the study. In the first analysis, the clinical and demographic properties of the cohort were defined. In the second analysis the effects of age, sex, clinical activity during course, initial clinical symptoms and cerebrospinal fluid analyses on the course were evaluated.
Results: Clinical activity during the course, older age, male gender, medulla spinalis involvement at onset and detection of paraparesis at initial neurological examination was found as a poor prognostic factor.
Conclusion: This research confirms previous findings of the studies conducted in populations of Europe and America. Further studies are needed to confirm and validate these findings and to provide greater insight into the effects of ethnic or geographical differences on the course. Copyright:
© 2022 Turkish Neuropsychiatric Society.

Entities:  

Keywords:  Multiple sclerosis; disability; progressive multiple sclerosis

Year:  2020        PMID: 35317497      PMCID: PMC8895799          DOI: 10.29399/npa.25046

Source DB:  PubMed          Journal:  Noro Psikiyatr Ars        ISSN: 1300-0667            Impact factor:   1.339


  21 in total

Review 1.  Natural history of primary progressive multiple sclerosis.

Authors:  George C Ebers
Journal:  Mult Scler       Date:  2004-06       Impact factor: 6.312

2.  Differences in the progression of primary progressive multiple sclerosis in Brazilians of African descent versus white Brazilian patients.

Authors:  Claudia Cristina Ferreira Vasconcelos; Luiz Claudio Santos Thuler; Gutemberg Augusto Cruz dos Santos; Marcos Papais Alvarenga; Marina Papais Alvarenga; Solange Maria das Graças Gomes Camargo; Regina Maria Papais Alvarenga
Journal:  Mult Scler       Date:  2010-02-18       Impact factor: 6.312

3.  Natural history of multiple sclerosis: a unifying concept.

Authors:  Christian Confavreux; Sandra Vukusic
Journal:  Brain       Date:  2006-01-16       Impact factor: 13.501

4.  Onset of progressive phase is an age-dependent clinical milestone in multiple sclerosis.

Authors:  Melih Tutuncu; Junger Tang; Nuhad Abou Zeid; Nilufer Kale; Daniel J Crusan; Elizabeth J Atkinson; Aksel Siva; Sean J Pittock; Istvan Pirko; B Mark Keegan; Claudia F Lucchinetti; John H Noseworthy; Moses Rodriguez; Brian G Weinshenker; Orhun H Kantarci
Journal:  Mult Scler       Date:  2012-06-26       Impact factor: 6.312

5.  Disease activity impacts disability progression in primary progressive multiple sclerosis.

Authors:  M Marrodan; C Bensi; A Pappolla; J I Rojas; M I Gaitán; M C Ysrraelit; L Negrotto; M P Fiol; L Patrucco; E Cristiano; M F Farez; J Correale
Journal:  Mult Scler Relat Disord       Date:  2019-12-14       Impact factor: 4.339

6.  The natural history of primary progressive multiple sclerosis.

Authors:  Marcus Koch; Elaine Kingwell; Peter Rieckmann; Helen Tremlett
Journal:  Neurology       Date:  2009-12-08       Impact factor: 9.910

7.  Age and disability accumulation in multiple sclerosis.

Authors:  A Scalfari; A Neuhaus; M Daumer; G C Ebers; P A Muraro
Journal:  Neurology       Date:  2011-09-14       Impact factor: 9.910

8.  Phases and Phenotypes of Multiple Sclerosis.

Authors:  Orhun H Kantarci
Journal:  Continuum (Minneap Minn)       Date:  2019-06

Review 9.  Natural history of multiple sclerosis: risk factors and prognostic indicators.

Authors:  Sandra Vukusic; Christian Confavreux
Journal:  Curr Opin Neurol       Date:  2007-06       Impact factor: 5.710

10.  Progressive Onset Multiple Sclerosis: Demographic, Clinical and Laboratory Characteristics of Patients With and Without Relapses in the Course.

Authors:  Bahar Kaymakamzade; Ahmet Kasım Kiliç; Aslı Tuncer Kurne; Rana Karabudak
Journal:  Noro Psikiyatr Ars       Date:  2018-07-04       Impact factor: 1.339

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.